CTR: Invest Alongside Saba Capital

Binary Tree Analytics profile picture
Binary Tree Analytics
2.97K Followers

Summary

  • CTR is a closed-end fund focused on MLP equities.
  • The vehicle has been trading at very substantial discounts to NAV since the Covid crisis.
  • Saba Capital, an activist hedge fund, has taken a position in the vehicle, and is moving forward with its intention to have independent directors join CTR.
  • Saba has a very robust track record in closing arbitrage gaps.
  • This article covers CEFs from our suite of products - we focus on macro portfolio allocation, CEFs, and yield-generating options strategies, targeting overall yearly portfolio returns of 9%+.

Oil pipeline in industrial district with factories at dusk

spooh

Thesis

ClearBridge Energy MLP Total Return Fund Inc (NYSE:CTR) is a closed end fund focused on MLP equities. As per its literature, CTR:

Offers a total-return oriented portfolio of primarily energy master limited partnerships and midstream entities. Provides the

Chart
Data by YCharts

expenses

Expenses (Fund Website)

seek

Total Return (seeking alpha)

return

Total Return (Seeking Alpha)

star

Premium / Discount to NAV (Morningstar)

hold

Holdings (Fund Fact Sheet)

sectors

Allocation (Fund Website)

This article was written by

Binary Tree Analytics profile picture
2.97K Followers
With a financial services cash and derivatives trading background, Binary Tree Analytics aims to provide transparency and analytics in respect to capital markets instruments and trades._____________________________http://www.BinaryTreeAnalytics.com

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.